Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marek Fiutowski"'
Publikováno v:
Miscellaneous.
Autor:
Maja Mrugała, Zofia Borowiec, Krzysztof Nowak, Marek Fiutowski, Mariusz Kasperski, Ewa Milnerowicz-Nabzdyk, Marcin Kalus
Publikováno v:
Quality of life after treatment.
Autor:
Krzysztof Ratajczyk, Andrzej Konieczny, Adrian Czekaj, Paweł Piotrów, Marek Fiutowski, Kornelia Krakowska, Paweł Kowal, Wojciech Witkiewicz, Karolina Marek-Bukowiec
Publikováno v:
International Journal of Environmental Research and Public Health. 19:9878
Effective biomarkers for early diagnosis, prognostication, and monitoring in renal diseases (in general) comprise an unmet need. Urinary retinol-binding protein 4, which is the most sensitive indicator of renal tubular damage, holds great promise as
Autor:
Marek Fiutowski, Marcin Słojewski, Piotr Chlosta, Jarosław Jaskulski, Tomasz Demkow, Michał Szymański, Tomasz Borkowski, Roman Sosnowski, Tomasz Szydełko, Jakub Dobruch
Publikováno v:
Central European Journal of Urology
Introduction Many options exist for the surgical treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), including transurethral resection of the prostate (TURP), laser surgery, and open adenomectomy. Recently, end
Autor:
Martin Cegan, Katarina Kolostova, Rafal Matkowski, Marek Broul, Jan Schraml, Marek Fiutowski, Vladimir Bobek
Publikováno v:
Scopus-Elsevier
Marek Broul
Wroclaw Medical University
Marek Broul
Wroclaw Medical University
Objective: Approximately one third of patients diagnosed with muscle-invasive urinary bladder cancer (UBC) have undetected metastases at the time of treatment of the primary tumor. Currently there are no reliable specific serum markers for monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::338f74785b63108655e418faf138d13e
http://www.scopus.com/inward/record.url?eid=2-s2.0-84912058457&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84912058457&partnerID=MN8TOARS
Autor:
Katarina Kolostova, Marek Broul, Jan Schraml, Martin Cegan, Rafal Matkowski, Marek Fiutowski, Vladimir Bobek
Publikováno v:
Scopus-Elsevier
Wroclaw Medical University
Wroclaw Medical University
The most promising near-term application of circulating tumor cells (CTCs) monitoring relates to the development of targeted cancer therapies, and the need to tailor such treatments to individual tumor characteristics. A high number of new innovative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::15a4d86d3cad5c99d02b9779fdf2da40
http://www.scopus.com/inward/record.url?eid=2-s2.0-84906324445&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84906324445&partnerID=MN8TOARS